Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes

F M Schaffer, J Palermos, Z B Zhu, B O Barger, M D Cooper, J E Volanakis, F M Schaffer, J Palermos, Z B Zhu, B O Barger, M D Cooper, J E Volanakis

Abstract

IgA deficiency and common variable immunodeficiency are heritable disorders that can occur within the same family. Both immunodeficiencies are characterized by arrests in B-cell differentiation that vary in the extent of the immunoglobulin isotypes involved. A high frequency of major histocompatibility complex supratypes associated with a null allele of the gene encoding the C4A isotype of complement component C4 has been observed in IgA-deficient individuals. In search of a genetic linkage between the two immunodeficiencies, we examined the major histocompatibility complex (MHC) class III genes encoding complement components C2, C4A, and C4B and steroid 21-hydroxylase in addition to the HLA serotypes in individuals with either common variable immunodeficiency or IgA deficiency. Twelve of 19 patients with common variable immunodeficiency (63%, P less than 0.001) and 9 of 16 patients with IgA deficiency (56%, P less than 0.01) had rare C2 alleles and/or C4A and 21-hydroxylase A deletions, whereas these gene features were seen in only 5 of 34 healthy individuals (15%) in the control group. Nine of 11 patients with C4A deletion had an HLA haplotype consistent with the MHC supratype HLA-A1, Cw7, B8, C4AQ0, C4B1, BfS, DR3 previously found to be associated with IgA deficiency. The data support the hypothesis that common variable immunodeficiency and IgA deficiency are related disorders, susceptibility to which is determined by a gene(s) within or near the MHC class III gene region on chromosome 6.

References

    1. Science. 1989 Jan 13;243(4888):214-7
    1. J Immunol. 1989 Mar 15;142(6):2105-11
    1. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1968-72
    1. EMBO J. 1989 Aug;8(8):2305-12
    1. Acta Med Scand. 1964 Jul;176:1-16
    1. N Engl J Med. 1984 Jul 26;311(4):235-42
    1. J Immunol. 1978 Apr;120(4):1169-75
    1. N Engl J Med. 1978 Jul 27;299(4):172-8
    1. J Rheumatol. 1978 Fall;5(3):288-93
    1. Clin Exp Immunol. 1979 Feb;35(2):296-305
    1. N Engl J Med. 1981 Apr 2;304(14):811-6
    1. N Engl J Med. 1981 Jun 11;304(24):1476-7
    1. N Engl J Med. 1981 Aug 27;305(9):495-7
    1. J Clin Invest. 1981 Sep;68(3):699-705
    1. Eur J Immunol. 1982 Jul;12(7):540-6
    1. Br Med J (Clin Res Ed). 1983 Feb 5;286(6363):425-8
    1. Int J Immunopharmacol. 1982;4(6):517-20
    1. J Immunol Methods. 1983 Mar 25;58(3):337-47
    1. Tissue Antigens. 1983 Jan;21(1):75-9
    1. Lancet. 1983 Oct 1;2(8353):787-8
    1. Anal Biochem. 1983 Jul 1;132(1):6-13
    1. J Clin Invest. 1984 Aug;74(2):634-8
    1. Proc Natl Acad Sci U S A. 1985 Feb;82(4):1089-93
    1. Immunogenetics. 1985;21(4):333-42
    1. Immunol Rev. 1985 Jul;85:45-86
    1. EMBO J. 1985 Oct;4(10):2547-52
    1. Immunogenetics. 1985;22(4):377-90
    1. Hum Immunol. 1986 Apr;15(4):366-73
    1. Lancet. 1971 Oct 9;2(7728):791-4
    1. Clin Immunol Immunopathol. 1973 Jan;1(2):241-56
    1. Lancet. 1974 Sep 14;2(7881):609-13
    1. J Mol Biol. 1975 Nov 5;98(3):503-17
    1. Clin Immunol Immunopathol. 1977 May;7(3):311-4
    1. Am J Clin Pathol. 1978 Feb;69(2):103-20
    1. N Engl J Med. 1986 Aug 21;315(8):488-95
    1. Science. 1987 Mar 27;235(4796):1616-22
    1. Immunogenetics. 1987;25(6):383-90
    1. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7237-41
    1. Science. 1988 Apr 8;240(4849):201-4

Source: PubMed

3
Abonnere